Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic Lymphomakinase- Positive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib için istatistikler
Toplam ziyaret
| views | |
|---|---|
| Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic Lymphomakinase- Positive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib | 1 |
Aylık toplam ziyaret
| views | |
|---|---|
| Nisan 2024 | 0 |
| Mayıs 2024 | 1 |
| Haziran 2024 | 0 |
| Temmuz 2024 | 0 |
| Ağustos 2024 | 0 |
| Eylül 2024 | 0 |
| Ekim 2024 | 0 |
Dosya Ziyaretleri
| views | |
|---|---|
| 1502.pdf | 3 |
